Clinical Trials

Clinical Trials homepage banner

CNF believes Clinical Trials are essential to finding new treatments and offering hope to children with neurologic conditions.

Families in our community told us they needed help understanding and finding clinical trials. Clinicians told us they needed resources to help families find and evaluate clinical trials. Our goal is to provide an educational hub with helpful and reliable information that addresses these needs for both communities.


Considering Clinical Trials? Start Here.

Why should I consider having my child participate in a clinical trial?

Joining a clinical trial can be a rewarding experience. Children and their families who join studies may:

  • Learn about new medicines and treatments
  • See specialized doctors and learn more about the child’s condition
  • Help other children and contribute to the advancement of treatments

Clinical trials also have risks. So, it is essential to learn everything you can about any clinical trial you consider.

What should I ask my doctor about a clinical trial?

Your child’s doctor may recommend a clinical trial for you to explore. Don’t hesitate to ask them if they know of a trial or to share a clinical trial you found. Your doctor may not know about every trial available.

Your doctor cannot tell you if you will qualify for a clinical trial. However, they can help you develop a list of questions to ask when you contact the clinical trial coordinators. They can also answer questions you may have after talking to the clinical trial coordinators.

How can I learn about clinical trials specific to my child’s condition?
  • Use the CNF Disorder Directory to:
    • Learn more about your child’s disorder
    • Get links to available trials
    • Connect with advocacy organizations
  • If your child does not currently have a diagnosis, consider visiting the Undiagnosed Disease Network and applying to be a part of their research study.
  • The Rare Diseases Clinical Research Network (RDCRN) is a national network of top rare disease researchers. It is powered by patient partnerships and funded by the National Institutes of Health. The RDCRN Contact Registry collects and stores the contact information of people who want to participate in RDCRN-sponsored research or learn more about their research.
  • RARE-X is a collaborative platform for global data sharing and analysis to accelerate treatments for rare diseases.
Are clinical trials suitable for my child?

Deciding if a clinical trial is a good option for your family and child is a personal choice. It involves many considerations. There is no right or wrong answer.

  • Part of the clinical trial process is “informed consent.” This makes sure parents are fully informed and can ask questions before starting the trial. See the Courageous Parents Network resources below for more information on informed consent. These resources may also help you evaluate a trial.
  • By enrolling in a clinical trial, you may be able to connect with other families. Finding others who are in a similar situation can be incredibly helpful.
  • Talking to your child’s medical providers can provide more information to help you make a decision.
What questions should I ask researchers to help guide my decision?
  • What is the purpose of the trial?
  • What kinds of tests and treatments are involved?
  • How much time will be required and how long will the trial take?
  • What are the possible side effects or risks?
  • What happens if I want to take my child out of the trial?
  • Will there be any costs we will have to pay?
  • How will the doctor know if the treatment is working?
  • How and when will we be told about the trial’s results?
Where can I find clinical trials?
Where can I learn more about how clinical trials work and what participation involves?
1Clinical Trials

Caregiver Clinical Trial Navigation Course

Clinical trials can bring up a lot at once: medical questions, practical considerations, and the emotional weight of making decisions for your child. The Caregiver Clinical Trial Navigation Course was created to help you understand how clinical trials work and how to evaluate them with clarity.

Each section includes a short video and supporting content, designed to be brief, focused, and easy to navigate. If you want to go deeper, you will find additional learning within each section.

Want a Certificate of Completion?

If you would like to earn a certificate, you can do that through our online learning. The online learning version includes the full course experience, including videos and completion tracking, so you can receive a certificate when you finish.


What You Will Learn

In this course, you will gain a clearer understanding of:

  • How clinical trials work, including phases and what each phase is designed to evaluate
  • Safety, ethics, and patient rights in pediatric trials, including oversight and protections
  • Informed consent and assent, and what families should expect from that process
  • Practical participation considerations, such as time commitments, travel, school, daily tracking, and family routines
  • How to communicate with your clinician and the research team, including what to ask and how to advocate for clarity
  • What happens after a trial ends, including follow up care, access questions, and next steps
  • How families are supported when a trial does not reach its endpoints
  • Why patient advocacy groups matter, and how they shape better trials

Section 1: Clinical Trial Phases

Clinical trials are how new medicines and treatments move from the lab into patient care. Trials happen in phases, and each phase answers different questions about safety, effectiveness, and long term use.

A Simple Overview of Clinical Trial Phases

Clinical research typically moves through phases, each designed to answer different questions.

  • Phase 0 explores how a drug behaves in the body in a very small group
  • Phase 1 focuses on safety and dosage, with close monitoring
  • Phase 2 looks at whether a treatment works for people with the condition, while continuing to assess safety
  • Phase 3 expands to a larger group to confirm safety and effectiveness, often compared to standard care or a placebo
  • Phase 4 happens after approval, monitoring longer term outcomes as a treatment is used more broadly

Phases of Clinical Trials

2Clinical Trials

Section 2: Safety, Ethics, and Participant Rights in Pediatric Clinical Trials

Children are not simply smaller adults, so treatments must be studied with pediatric needs in mind. Trials follow strict ethical principles focused on well being, minimizing stress, and ensuring fairness and transparency.

Safety is monitored before a trial begins and throughout participation, with independent oversight and ongoing review. Participation is voluntary, parents provide permission, and children who are able can provide assent. Families can stop participation at any time, and privacy is protected.

Fairness in Clinical Trials

11Clinical Trials

Safety in Clinical Trials

12Clinical Trials

Saying Yes or No to Entering a Clinical Trial

13Clinical Trials

Leaving a Clinical Trial

14Clinical Trials

Section 3: Participation and Practical Considerations

Beyond medical details, participation affects everyday life. It helps to understand the schedule, the time commitment, travel expectations, and whether there is support for costs like parking or meals.

It is also worth thinking through sibling logistics, daily tracking requirements, and your child’s comfort with tests. You know your family best, and it is okay to ask direct questions about what participation looks like in real life.

Participation and Practical Considerations

What Participation Can Look Like in Real Life

Clinical trials affect everyday life, not just medical care. This video focuses on the real world logistics that can help families plan and feel prepared.

  • Visit schedules and how they may affect school and work
  • Travel expectations and whether support is available for costs
  • Sibling logistics and family routines
  • Daily tracking tools like apps or symptom diaries
  • Supports that can help children feel safe during procedures
6Clinical Trials

Section 4: Understanding Informed Consent

Informed consent is an ongoing conversation, not just a form. Its purpose is to make sure you understand what a trial involves, including risks, benefits, procedures, and alternatives, so you can decide what is right for your child and your family.

Many pediatric trials also include assent, giving children an age appropriate way to share their willingness to participate. You can ask questions at any point, take time to decide, and revisit the conversation whenever needed.

Understanding Informed Consent

Informed consent is intended to support clear decision making by outlining procedures, risks, potential benefits, alternatives, and what changes might occur during the study. This video explains what it includes and how caregivers can use it to make decisions that fit their child and family.

  • What informed consent should cover, including risks, benefits, and alternatives
  • How assent gives children an age appropriate voice when possible
  • Your right to ask questions and take time before deciding
  • Your right to receive updates if risks or procedures change
4Clinical Trials

Section 5: Communicating With Researchers

Caregivers are key partners in clinical trials, because you know your child’s day to day patterns and changes. Strong communication helps make sure your child’s needs and experiences are understood.

This section includes practical ways to ask questions, request plain language explanations, use the teach back method, and track changes through a study log. It also reinforces that if something feels unclear, you can ask for more information and request support.

Communicating With Researchers

Clear communication with the research team helps families understand expectations, report meaningful changes, and address concerns promptly as they arise. This video shares practical ways to communicate clearly and advocate for understanding.

  • Questions to ask about goals, side effects, and emergency plans
  • How to request plain language explanations
  • Using the teach back method to confirm understanding
  • Keeping a study log to track daily changes that matter
  • What to do if something feels unclear or concerning
5Clinical Trials

Section 6: Life After a Pediatric Clinical Trials

After a trial ends, some families move into follow up care and monitoring, and the next steps depend on the child’s health and the study’s outcomes. This section covers what families may encounter after participation, including mixed results, access questions, and how care teams and patient advocacy organizations can help families navigate options and next steps.

Life After a Pediatric Clinical Trials

After a trial concludes, families may need guidance on follow up care, next steps, and how to interpret results, particularly when outcomes are complex or still emerging.

  • Follow up monitoring and longer term care planning
  • Why results may be strong, mixed, or uncertain
  • When access may involve follow up studies or expanded use pathways
  • Where families may find help navigating coverage and support options
  • Staying connected to care teams and patient communities for updates
7Clinical Trials

Section 7: Establishing a New Medical Home

A medical home is a coordinated care team that understands your child’s history and helps support continuity after a clinical trial ends. This section explains what coordinated care can look like, how to transfer trial records, and how communication across providers can reduce gaps in care.

Establishing A New Medical Home

After a trial ends, many families shift into a new phase of coordinated care. This video explains what a medical home is and how it supports continuity.

  • What a medical home means and who may be part of the team
  • Why coordination matters after trial participation
  • How to transfer trial records and plan follow up care
  • Keeping specialists, therapists, and schools aligned when appropriate
  • What to look for when choosing the right care team
8Clinical Trials

Section 8: When a Clinical Trial Does Not Reach Its Endpoints

When a trial does not reach its planned endpoints, families may feel disappointment and uncertainty. This video focuses on support, next steps, and maintaining continuity of care.

When a Clinical Trial Does Not Reach Its Endpoints

After a trial ends, many families shift into a new phase of coordinated care. This video explains what a medical home is and how it supports continuity.

  • Why endpoints matter and what it means when they are not reached
  • Emotional support options, including counseling and peer support
  • Follow up planning and record transfer
  • How families may explore future options with trusted clinicians
  • Practical steps to regain clarity after a difficult outcome
9Clinical Trials

Section 9: Why Patient Advocacy Groups Matter

Patient advocacy groups help shape clinical trials by bringing together families, clinicians, and researchers so studies reflect real world needs and priorities. This section explains how advocacy groups support education, decision making, and study design, and why their role is especially important in rare and undiagnosed communities.

Why Patient Advocacy Groups Matter

Patient advocacy groups help make clinical trials more relevant, ethical, and feasible. This video explains how they support families and strengthen research.

  • How advocacy groups connect families, clinicians, and researchers
  • Education and guidance that supports informed decision making
  • Lived experience insights that improve study design and endpoints
  • How partnership can improve trust, recruitment, and retention
  • Why advocacy is especially vital in rare and undiagnosed communities
10Clinical Trials

Thank You To Our Sponsors

  • ACAD RM RGB FC Pos
  • UCB Logo Tagline ReflexBlue CMYK
  • LUNDBECK logo RGB.png.coredownload
  • neurogene

The information in the CNF Clinical Trials section is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.